Patrick M. Allen Cabinet Secretary for the Department of Health | Office of Governor Michelle Lujan Grisham
Patrick M. Allen Cabinet Secretary for the Department of Health | Office of Governor Michelle Lujan Grisham
Respiratory Syncytial Virus (RSV) immunizations are now available for older adults and pregnant individuals as the respiratory season begins. RSV antibodies are also accessible for infants, who are particularly susceptible to the virus during their first year. RSV is a leading cause of infant hospitalization in both New Mexico and across the United States.
The activity of RSV generally rises in the fall, reaching its peak around December and January. Dr. Miranda Durham, Chief Medical Officer for the New Mexico Department of Health (NMHealth), stated, “It’s very exciting to have RSV vaccines added to the tools we have to stay healthy during the winter.” She emphasized that early immunization could reduce severe disease risks that might lead to hospitalization or death.
For infants, protection against RSV can be achieved through two methods: Nirsevimab is recommended for children aged eight to 19 months who meet specific criteria. For high-risk children, immediate administration of Nirsevimab is advised. Last season's data indicated that Nirsevimab was 80-90% effective in preventing hospitalizations due to RSV among babies. No shortages of this antibody are expected this year.
Older residents of New Mexico also face significant risks from severe RSV infections. Vaccination is advised for those aged 75 and older and for individuals aged 60 and above with chronic medical conditions. The vaccine can be administered at any time, with only one dose currently recommended per person annually.
RSV vaccines are available at various locations such as healthcare provider offices, pharmacies, and hospitals. NMHealth encourages insured individuals to consult their healthcare providers or pharmacists about receiving the vaccine. For those without insurance or unable to access vaccination otherwise, NMHealth provides vaccinations.
Nirsevimab is included in the federal Vaccines for Children program, ensuring all children in New Mexico can receive it regardless of insurance status.
To locate a site offering the RSV vaccine or if assistance is needed regarding vaccination inquiries, individuals can contact the NMHealth Help Line at 1-833-796-8773 (1-833-SWNURSE). Further information about this press release can be obtained by contacting David Barre at (505) 699-9237 (Office).
A Spanish version of this press release is also available for increased accessibility.
Alerts Sign-up